Xenon Pharmaceuticals Inc
0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price 31.60
Ask Price 41.70
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Xenon Pharmaceuticals Inc XENE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 36.17 04:00:11
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 24.94 - 41.39
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 36.17 USD

Xenon Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.28B 63.04M 62.31M $ 9.43M $ -7.97M -2.04 -19.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 0.90%

more financials information »

Xenon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No XENE Message Board. Create One! See More Posts on XENE Message Board See More Message Board Posts

Historical XENE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week33.9136.5832.9434.82492,3142.266.66%
1 Month40.0040.0032.6435.36459,981-3.83-9.58%
3 Months37.2641.2532.6436.94408,852-1.09-2.93%
6 Months35.8641.2531.7936.66383,2860.310.86%
1 Year30.2141.3924.9434.59430,0535.9619.73%
3 Years10.9441.399.3228.93450,32225.23230.62%
5 Years4.9041.394.5025.45335,57931.27638.16%

Xenon Pharmaceuticals Description

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.